These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10632626)

  • 1. Positron emission tomography: establishing priorities for health technology assessment.
    Robert G; Milne R
    Health Technol Assess; 1999; 3(16):1-54. PubMed ID: 10632626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Delphi study to establish national cost-effectiveness research priorities for positron emission tomography.
    Robert G; Milne R
    Eur J Radiol; 1999 Apr; 30(1):54-60. PubMed ID: 10389013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner?
    Langer A
    BMC Health Serv Res; 2010 Oct; 10():283. PubMed ID: 20932288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging using gamma camera systems: a review.
    Jarritt PH; Acton PD
    Nucl Med Commun; 1996 Sep; 17(9):758-66. PubMed ID: 8895903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.
    Verboom P; van Tinteren H; Hoekstra OS; Smit EF; van den Bergh JH; Schreurs AJ; Stallaert RA; van Velthoven PC; Comans EF; Diepenhorst FW; van Mourik JC; Postmus PE; Boers M; Grijseels EW; Teule GJ; Uyl-de Groot CA;
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1444-9. PubMed ID: 14579081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirements for clinical PET: comparisons within Europe.
    Bedford M; Maisey MN
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):208-21. PubMed ID: 15129703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
    Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy.
    Gugiatti A; Grimaldi A; Rossetti C; Lucignani G; De Marchis D; Borgonovi E; Fazio F
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):49-61. PubMed ID: 15195004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.
    Claxton K; Ginnelly L; Sculpher M; Philips Z; Palmer S
    Health Technol Assess; 2004 Jul; 8(31):1-103, iii. PubMed ID: 15248937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of surrogate outcomes in model-based cost-effectiveness analyses: a survey of UK Health Technology Assessment reports.
    Taylor RS; Elston J
    Health Technol Assess; 2009 Jan; 13(8):iii, ix-xi, 1-50. PubMed ID: 19203465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An approach to demonstrating cost-effectiveness of diagnostic imaging modalities in Australia illustrated by positron emission tomography.
    Miles KA
    Australas Radiol; 2001 Feb; 45(1):9-18. PubMed ID: 11259966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging using gamma cameras.
    D'Asseler Y; Vandenberghe S; Winter FD; Van de Walle R; Koole M; Bouwens L; Lemahieu I; Dierckx RA
    Comput Med Imaging Graph; 2001; 25(2):87-96. PubMed ID: 11137784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moving Forward Through Consensus: A Modified Delphi Approach to Determine the Top Research Priorities in Orthopaedic Oncology.
    Schneider PJ; Evaniew N; McKay P; Ghert M
    Clin Orthop Relat Res; 2017 Dec; 475(12):3044-3055. PubMed ID: 28856514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What are the relative merits of the sources used to identify potential research priorities for the NHS HTA programme?
    Chase D; Milne R; Stein K; Stevens A
    Int J Technol Assess Health Care; 2000; 16(3):743-50. PubMed ID: 11028130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying research priorities for effective retention strategies in clinical trials.
    Kearney A; Daykin A; Shaw ARG; Lane AJ; Blazeby JM; Clarke M; Williamson P; Gamble C
    Trials; 2017 Aug; 18(1):406. PubMed ID: 28859674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of positron emission tomography in the clinical evaluation of dementia.
    Gill SS; Rochon PA; Guttman M; Laupacis A
    J Am Geriatr Soc; 2003 Feb; 51(2):258-64. PubMed ID: 12558725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between systematic reviews and health technology assessments: a trade-off between the ideals of scientific rigor and the realities of policy making.
    Rotstein D; Laupacis A
    Int J Technol Assess Health Care; 2004; 20(2):177-83. PubMed ID: 15209177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron Emission Mammography (PEM) in the diagnosis of breast cancer: A systematic review and economic evaluation.
    Keshavarz K; Jafari M; Lotfi F; Bastani P; Salesi M; Gheisari F; Rezaei Hemami M
    Med J Islam Repub Iran; 2020; 34():100. PubMed ID: 33315994
    [No Abstract]   [Full Text] [Related]  

  • 20. Physical principles and technology of clinical PET imaging.
    Townsend DW
    Ann Acad Med Singap; 2004 Mar; 33(2):133-45. PubMed ID: 15098626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.